Guzzeloni, V.; Veschini, L.; Pedica, F.; Ferrero, E.; Ferrarini, M.
3D Models as a Tool to Assess the Anti-Tumor Efficacy of Therapeutic Antibodies: Advantages and Limitations. Antibodies 2022, 11, 46.
https://doi.org/10.3390/antib11030046
AMA Style
Guzzeloni V, Veschini L, Pedica F, Ferrero E, Ferrarini M.
3D Models as a Tool to Assess the Anti-Tumor Efficacy of Therapeutic Antibodies: Advantages and Limitations. Antibodies. 2022; 11(3):46.
https://doi.org/10.3390/antib11030046
Chicago/Turabian Style
Guzzeloni, Virginia, Lorenzo Veschini, Federica Pedica, Elisabetta Ferrero, and Marina Ferrarini.
2022. "3D Models as a Tool to Assess the Anti-Tumor Efficacy of Therapeutic Antibodies: Advantages and Limitations" Antibodies 11, no. 3: 46.
https://doi.org/10.3390/antib11030046
APA Style
Guzzeloni, V., Veschini, L., Pedica, F., Ferrero, E., & Ferrarini, M.
(2022). 3D Models as a Tool to Assess the Anti-Tumor Efficacy of Therapeutic Antibodies: Advantages and Limitations. Antibodies, 11(3), 46.
https://doi.org/10.3390/antib11030046